Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹69 Cr
Revenue (TTM)
₹94 Cr
Net Profit (TTM)
₹-5 Cr
ROE
-11.6 %
ROCE
-6.8 %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
126.84
EV/EBITDA
20.3
Div. Yield
0 %
Debt to Equity
0
Book Value
₹20.5
EPS
₹-0.4
Face value
10
Shares outstanding
87,405,767
CFO
₹17.49 Cr
EBITDA
₹20.02 Cr
Net Profit
₹-24.44 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
JHS Svendgaard Lab
| -19.1 | -22.2 | -20.4 | -36.2 | -21.3 | -19.0 | -10.1 |
|
BSE FMCG
| -14.5 | -10.3 | -13.8 | -9.5 | 2.2 | 7.0 | 8.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
JHS Svendgaard Lab
| -57.7 | -16.4 | 13.9 | -18.7 | 14.6 | 56.2 | -56.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE FMCG
| -2.1 | 1.5 | 27.3 | 16.6 | 9.3 | 10.5 | -3.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
JHS Svendgaard Lab
|
7.9 | 69.5 | 94.2 | -5.3 | -9.3 | -1.8 | -- | 0.4 |
| 106.9 | 102.2 | 1.4 | -3.3 | -87.6 | -2.8 | -- | 3.3 | |
| 1,889.7 | 51,393.1 | 5,902.2 | 1,327.0 | 29.0 | 82.1 | 38.7 | 27.0 | |
| 78.8 | 10,589.2 | 299.2 | 83.5 | 30.9 | 23.1 | 126.8 | 20.3 | |
| 405.7 | 17,691.4 | 3,817.5 | 798.5 | 21.4 | 28.6 | 22.3 | 5.4 | |
| 7,984.5 | 26,012.9 | 3,075.0 | 620.5 | 26.3 | 56.8 | 41.9 | 19.5 | |
| 277.0 | 9,011.1 | 2,268.4 | 155.8 | 6.2 | 13 | 57.9 | 6.8 | |
| 209.1 | 13.1 | 5.8 | -0.2 | -23.6 | -- | -- | -7.3 | |
| 387.7 | 672.1 | 278.6 | 12.8 | 5.4 | 8.7 | 51.3 | 4.0 |
No Review & Analysis are available.
JHS Svendgaard Laboratories Limited, together with its subsidiaries, manufactures, trades, and sells a range of oral and dental products for adults and kids in India. The company offers oral care products, such as toothbrushes, toothpastes, mouthwash... products, hand sanitizers, laundry detergents, room fresheners, and denture tablet products under the Dr. Gold, Dr. Fresh, Boots, Lavoris, Peanuts, Amway, Dabur, Future Group, Apollo Pharmacy, Sandika Pharma, Elder Pharma, JL Morisons, Aquawhite, 6 Ten Store, Modi Care, Infectiguard, and Odonil brands. It also provides contract manufacturing services for oral care products of other brands. The company also exports its products. JHS Svendgaard Laboratories Limited was founded in 1997 and is based in New Delhi, India. Read more
Incorporated
2004
Chairman
Rajagopal Chakravarthi Venkateish
Managing Director
Nikhil Nanda
Headquarters
Sirmour Dist, Himachal Pradesh
Website
Looking for more details about JHS Svendgaard Laboratories Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of JHS Svendgaard Laboratories Ltd is ₹7.94 (NSE) and ₹7.95 (BSE) as of 19-Mar-2026 IST. JHS Svendgaard Laboratories Ltd has given a return of -21.32% in the last 3 years.
Since, TTM earnings of JHS Svendgaard Laboratories Ltd is negative, P/E ratio is not available.
The P/B ratio of JHS Svendgaard Laboratories Ltd is 0.39 times as on 19-Mar-2026, a 89 discount to its peers’ median range of 3.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.56
|
|
2024
|
0.00
|
0.76
|
|
2023
|
0.00
|
0.71
|
|
2022
|
0.00
|
0.72
|
|
2021
|
107.20
|
0.72
|
The 52-week high and low of JHS Svendgaard Laboratories Ltd are Rs 16.46 and Rs 7.56 as of 20-Mar-2026.
JHS Svendgaard Laboratories Ltd has a market capitalisation of ₹ 69 Cr as on 19-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in JHS Svendgaard Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.14
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.